Format

Send to

Choose Destination
See comment in PubMed Commons below
Int Perspect Sex Reprod Health. 2013 Dec;39(4):195-204. doi: 10.1363/3919513.

Consumer perspectives on a pericoital contraceptive pill in India and Uganda.

Author information

1
Program Officer, PATH, Seattle, WA, USA, jcover@path.org.

Abstract

CONTEXT:

Studies suggest that women in some countries have adopted emergency contraceptive pills as a routine method of family planning. This practice indicates there may be latent demand for a pericoital contraceptive pill taken only when a woman has sexual intercourse, and labeled and marketed for use as a regular contraceptive method.

METHODS:

To understand the appeal and potential market for a pericoital contraceptive pill, 39 focus groups and 23 in-depth interviews were conducted with women and men in Lucknow, Uttar Pradesh, India, and Kampala, Uganda. A total of 281 individuals participated in this qualitative study.

RESULTS:

In general, women embraced the idea of a female-controlled method that would be easier than taking a daily oral contraceptive pill and that could be taken either before or after sexual intercourse; in Uganda, especially, women approved of the fact that the method could be taken without a partner's knowledge. Although we do not yet know the extent of side effects for this method, women expressed some concerns about the level and nature of potential side effects.

CONCLUSIONS:

The results suggest that a pericoital contraceptive pill would be well-received by consumers in both country settings. If its efficacy and side effects are acceptable, a pericoital contraceptive pill could fill a gap for female-controlled, discreet, coitus-related contraception, particularly among women who do not have sex very frequently.

PMID:
24393725
DOI:
10.1363/3919513
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for The Alan Guttmacher Institute
    Loading ...
    Support Center